These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

499 related articles for article (PubMed ID: 20004006)

  • 1. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis.
    Kowalska MA; Rauova L; Poncz M
    Thromb Res; 2010 Apr; 125(4):292-6. PubMed ID: 20004006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
    Prechel MM; Jeske WP; Walenga JM
    Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of platelet factor 4 with the vessel wall.
    Sachais BS; Higazi AA; Cines DB; Poncz M; Kowalska MA
    Semin Thromb Hemost; 2004 Jun; 30(3):351-8. PubMed ID: 15282658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet chemokines in health and disease.
    Karshovska E; Weber C; von Hundelshausen P
    Thromb Haemost; 2013 Nov; 110(5):894-902. PubMed ID: 23783401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions.
    Baltus T; von Hundelshausen P; Mause SF; Buhre W; Rossaint R; Weber C
    J Leukoc Biol; 2005 Aug; 78(2):435-41. PubMed ID: 15899984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prothrombotic potential of platelet factor 4.
    Thachil J
    Eur J Intern Med; 2010 Apr; 21(2):79-83. PubMed ID: 20206875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense.
    Gear AR; Camerini D
    Microcirculation; 2003 Jun; 10(3-4):335-50. PubMed ID: 12851650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet factor 4: a chemokine enigma.
    Slungaard A
    Int J Biochem Cell Biol; 2005 Jun; 37(6):1162-7. PubMed ID: 15778080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: a study of 44 cases.
    Amiral J; Bridey F; Wolf M; Boyer-Neumann C; Fressinaud E; Vissac AM; Peynaud-Debayle E; Dreyfus M; Meyer D
    Thromb Haemost; 1995 Jan; 73(1):21-8. PubMed ID: 7740492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
    Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
    J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-derived chemokines in inflammation and atherosclerosis.
    Bakogiannis C; Sachse M; Stamatelopoulos K; Stellos K
    Cytokine; 2019 Oct; 122():154157. PubMed ID: 29198385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presence of autoantibodies to interleukin-8 or neutrophil-activating peptide-2 in patients with heparin-associated thrombocytopenia.
    Amiral J; Marfaing-Koka A; Wolf M; Alessi MC; Tardy B; Boyer-Neumann C; Vissac AM; Fressinaud E; Poncz M; Meyer D
    Blood; 1996 Jul; 88(2):410-6. PubMed ID: 8695787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
    Francis JL
    Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond the platelet count: heparin antibodies as independent risk predictors.
    Stribling WK; Slaughter TF; Houle TT; Sane DC
    Am Heart J; 2007 Jun; 153(6):900-6. PubMed ID: 17540189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of antibodies to the platelet factor 4 -heparin complex and association with access thrombosis in patients on chronic hemodialysis.
    Carrier M; Knoll GA; Kovacs MJ; Moore JC; Fergusson D; Rodger MA
    Thromb Res; 2007; 120(2):215-20. PubMed ID: 17098277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
    Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
    Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heparin-induced platelet aggregation vs platelet factor 4 enzyme-linked immunosorbent assay in the diagnosis of heparin-induced thrombocytopenia-thrombosis.
    Look KA; Sahud M; Flaherty S; Zehnder JL
    Am J Clin Pathol; 1997 Jul; 108(1):78-82. PubMed ID: 9208982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A modified PF4-dependent, CD62p expression assay selectively detects serotonin-releasing antibodies in patients suspected of HIT.
    Padmanabhan A; Jones CG; Bougie DW; Curtis BR; McFarland JG; Wang D; Aster RH
    Thromb Haemost; 2015 Nov; 114(6):1322-3. PubMed ID: 26177881
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heparin-platelet factor 4 antibodies in patients presenting to the ED with thrombosis.
    Francis JL; Drexler A; Duncan MK; Walker JM; Hursting MJ; Levine RL
    Am J Emerg Med; 2007 Mar; 25(3):279-84. PubMed ID: 17349901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.